跳至主要内容
临床试验/NCT01966146
NCT01966146已完成不适用

Quantitative Analysis of Catheter-based Interventional Therapies for Treating Valve Insufficiency by Using 3D Echocardiography.

RWTH Aachen University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Quantitative analysis of geometric changes and heart function after heart valve replacement and reconstruction respectively by 3D echocardiographic procedures

研究概览

简要总结

Aim of the study is the definition of criteria for a standardized assessment of heart function by 3D echocardiographic procedures. Standardized criteria will be defined to assess aortic valve insufficiency after TAVI and success of mitral valve replacement respectively.

详细描述

Echocardiography: GE Healthcare Vivid E9

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients with severe symptoms of an aortic stenosis who underwent catheter based implantation of an aortic valve
  • •patients who are planned to undergo a reconstruction of the mitral valve with the MitraClip System
  • •Patients who are aged above 18 years and legally competent
  • •signed informed consent

排除标准

  • •patients with previous myocard infarction, previous heart surgeries, malignity or valvular abnormities > stage 1
  • •patients with atrial fibrillation
  • •pregnant and breast-feeding women
  • •patients with disturbed central nerve system
  • •patients with pacemaker, implants, ferrous clamps,insulin pump
  • •patients with tattoo
  • •patients with claustrophobia
  • •patiens with asthma

研究组 & 干预措施

TAVI

Experimental

Echocardiography after TAVI

干预措施: Echography GE Healthcare Vivid E9 (Device)

MitraClip

Experimental

Echocardiography after MitraClip procedure

干预措施: Echography GE Healthcare Vivid E9 (Device)

结局指标

主要结局

Quantitative analysis of geometric changes and heart function after heart valve replacement and reconstruction respectively by 3D echocardiographic procedures

时间窗: Analysis will be performed after heart valve replacement or reconstruction procedures and after 6 month

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验